Ascendis Pharma A/S (A1SN34M) Cotización

$ASII 3 Day Weekend Next Week We Rock 😎

I did the same . Nice to share info without all the spam .

💩💩💩💩 Not even insiders believe Fraudster Fahman 💩 anymore .....Lot of SELLERS @ O.OOO2 R lining (💩ing) up today that r stuck in PHIL, their major problem is few to no buyers r lining up @ O.OOO3 to bail them out 'a of this pile of 💩

I see him as having basically a more healthy level of skepticism, most of the time.

As soon as they want really. All requirements are satisfied right now for the NYSE.

Ok then, plausible it is 😂

Oh wow.  $20 on deck.  Could even be more.  New products and services will be available for all the customers in the world to enjoy and experience in the future and be able to share with others who have been affected by the pandemic.  Oh wow.  Oh boy oh girl.

Looking forward to the remainder of January as interest grows in SGTM!

And the plan is to short this stock into oblivion so that the drug will never see the light of day.

Get a grip on yourself. It doesn't matter what the plan of the shorts is if Blarcamesine receives regulatory approval either in Europe or the U.S.

Praise be...
https://scontent-lax3-1.xx.fbcdn.net/v/t39.30808-6/473786739_1069602248604682_7892679461177338488_n.jpg?_nc_cat=109&ccb=1-7&_nc_sid=833d8c&_nc_ohc=pnF6gnZLrIoQ7kNvgGoq-Wq&_nc_zt=23&_nc_ht=scontent-lax3-1.xx&_nc_gid=A0CJ5sEUqKngs-gzkH2sIhO&oh=00_AYB5VEL9lB_pK0CNopu_oH1Zfhl-iZ54x3z

Apparently you know about a PR coming. That's insider trading. If 1 comes out, I'll make sure SEC knows 1 way or another about your posts here.Don't worry

Acknowledgments
The authors would like to thank Dr. Thomas J. Hawke for access to the upright microscope and Dr. Jonathan D. Schertzer for access to and Dr. Nicole G. Barra for calibration of the Bio-Plex instrument. This research was supported by grants awarded to G.R.S. from the Canadian In

Miami, like it or not, the 'real facts' are in the financial statements. THAT is the most important and major reason this is trading .0002/.0003. Every stock investment evaluation starts with the financials. Are they making money or are they losing money? Do they have more assets than liabilities, i

SGTM uses a groundbreaking carbon capture technology that goes beyond just mitigating emissions.
https://img1.wsimg.com/isteam/ip/9f8df632-1291-4de6-ae2e-6cd4239755a5/ols/IMG_5359.jpeg/:/cr=t:0%25,l:0%25,w:100%25,h:100%25/rs=w:1280

Andy should buy shares to show confidence in the company.

How soon could it be that we are on the NYSE?

All it takes is a flash flood of OTC buyers again like 2021!

All this whole RNVA FOXO thing was obviously contingent on Seamus moving those assets and him becoming ceo. Seamus has a plan alright and it seems it was to benefit himself. We shall see....I still don't get the point. If RNVA is the "moneymaker" and Filter has graciously reminded us that FOXO was b

They steal $$$$. I heard horror stories about people who lost more than they gained.

"Ask not what you can do for your country, ask what you can do for me!"

Mike - I agree, the world doesn't need an new AD drug (sarcasm obviously). They love to slap around stocks held mostly by retail. It takes weeks and months to get this stock up and days to drop it back down. The shorts are in complete control even after a major publication of the data and signed

Needs a PR push

KR3 - Your analysis has not aged very well.
PLUG Longs got hosed today.  A pure Pump and Dump.

Don't trust anyone who says "buy Plug" or things are fine.  

"Although most doctors are incredibly honest, ethical people who only want to help patients, physicians are human and potentially vulnerable to influence from outside. Money is a prime suspect for undue influence, and it's probably no surprise that pharmaceutical companies spend billions annually to

What i don't get is why, why, and why the HUGE connection

to Canada with this research??

Has this publication been debated to death on st already, if it has i completely missed that on st.

This is huge and is a good indication into what that liver indicat